nodes	percent_of_prediction	percent_of_DWPC	metapath
Ofloxacin—TOP2A—Epirubicin—testicular cancer	0.0986	0.126	CbGbCtD
Ofloxacin—TOP2A—Etoposide—testicular cancer	0.0768	0.0982	CbGbCtD
Ofloxacin—ABCC1—Dactinomycin—testicular cancer	0.0754	0.0965	CbGbCtD
Ofloxacin—SLC22A5—Dactinomycin—testicular cancer	0.0717	0.0917	CbGbCtD
Ofloxacin—ABCC1—Epirubicin—testicular cancer	0.0546	0.0699	CbGbCtD
Ofloxacin—TOP2A—Doxorubicin—testicular cancer	0.0524	0.067	CbGbCtD
Ofloxacin—ABCC1—Vinblastine—testicular cancer	0.0472	0.0604	CbGbCtD
Ofloxacin—ABCC1—Etoposide—testicular cancer	0.0426	0.0544	CbGbCtD
Ofloxacin—ABCC2—Carboplatin—testicular cancer	0.0375	0.048	CbGbCtD
Ofloxacin—ABCC2—Vinblastine—testicular cancer	0.035	0.0447	CbGbCtD
Ofloxacin—ABCC2—Cisplatin—testicular cancer	0.0321	0.041	CbGbCtD
Ofloxacin—ABCC2—Etoposide—testicular cancer	0.0315	0.0403	CbGbCtD
Ofloxacin—ABCC1—Doxorubicin—testicular cancer	0.029	0.0371	CbGbCtD
Ofloxacin—ABCC1—Methotrexate—testicular cancer	0.0281	0.036	CbGbCtD
Ofloxacin—ABCC2—Doxorubicin—testicular cancer	0.0215	0.0275	CbGbCtD
Ofloxacin—ABCC2—Methotrexate—testicular cancer	0.0208	0.0266	CbGbCtD
Ofloxacin—SLC22A6—Methotrexate—testicular cancer	0.0152	0.0195	CbGbCtD
Ofloxacin—CYP1A2—Etoposide—testicular cancer	0.0117	0.015	CbGbCtD
Ofloxacin—TOP2A—Vindesine—Vinblastine—testicular cancer	0.000822	0.188	CbGdCrCtD
Ofloxacin—TOP2A—Vinorelbine—Vinblastine—testicular cancer	0.000519	0.118	CbGdCrCtD
Ofloxacin—TOP2A—Teniposide—Etoposide—testicular cancer	0.000518	0.118	CbGdCrCtD
Ofloxacin—TOP2A—Podofilox—Etoposide—testicular cancer	0.000518	0.118	CbGdCrCtD
Ofloxacin—TOP2A—Vincristine—Vinblastine—testicular cancer	0.000443	0.101	CbGdCrCtD
Ofloxacin—TOP2A—Daunorubicin—Epirubicin—testicular cancer	0.00027	0.0617	CbGdCrCtD
Ofloxacin—TOP2A—Doxorubicin—Epirubicin—testicular cancer	0.00027	0.0617	CbGdCrCtD
Ofloxacin—TOP2A—Idarubicin—Epirubicin—testicular cancer	0.00027	0.0617	CbGdCrCtD
Ofloxacin—TOP2A—Idarubicin—Doxorubicin—testicular cancer	0.00025	0.0571	CbGdCrCtD
Ofloxacin—TOP2A—Daunorubicin—Doxorubicin—testicular cancer	0.00025	0.0571	CbGdCrCtD
Ofloxacin—TOP2A—Epirubicin—Doxorubicin—testicular cancer	0.00025	0.0571	CbGdCrCtD
Ofloxacin—Pharyngitis—Epirubicin—testicular cancer	7.3e-05	0.000341	CcSEcCtD
Ofloxacin—Cardiac disorder—Methotrexate—testicular cancer	7.29e-05	0.000341	CcSEcCtD
Ofloxacin—Urinary tract disorder—Epirubicin—testicular cancer	7.26e-05	0.000339	CcSEcCtD
Ofloxacin—Oedema peripheral—Epirubicin—testicular cancer	7.24e-05	0.000339	CcSEcCtD
Ofloxacin—Haematuria—Doxorubicin—testicular cancer	7.23e-05	0.000338	CcSEcCtD
Ofloxacin—Connective tissue disorder—Epirubicin—testicular cancer	7.23e-05	0.000338	CcSEcCtD
Ofloxacin—Urethral disorder—Epirubicin—testicular cancer	7.21e-05	0.000337	CcSEcCtD
Ofloxacin—Hepatobiliary disease—Doxorubicin—testicular cancer	7.17e-05	0.000335	CcSEcCtD
Ofloxacin—Epistaxis—Doxorubicin—testicular cancer	7.15e-05	0.000334	CcSEcCtD
Ofloxacin—Angiopathy—Methotrexate—testicular cancer	7.13e-05	0.000333	CcSEcCtD
Ofloxacin—Sinusitis—Doxorubicin—testicular cancer	7.11e-05	0.000332	CcSEcCtD
Ofloxacin—Immune system disorder—Methotrexate—testicular cancer	7.1e-05	0.000332	CcSEcCtD
Ofloxacin—Visual impairment—Epirubicin—testicular cancer	7.09e-05	0.000331	CcSEcCtD
Ofloxacin—Mediastinal disorder—Methotrexate—testicular cancer	7.08e-05	0.000331	CcSEcCtD
Ofloxacin—Agranulocytosis—Doxorubicin—testicular cancer	7.07e-05	0.000331	CcSEcCtD
Ofloxacin—Chills—Methotrexate—testicular cancer	7.05e-05	0.00033	CcSEcCtD
Ofloxacin—Nausea—Ifosfamide—testicular cancer	7.01e-05	0.000328	CcSEcCtD
Ofloxacin—Diarrhoea—Cisplatin—testicular cancer	6.96e-05	0.000325	CcSEcCtD
Ofloxacin—Erythema multiforme—Epirubicin—testicular cancer	6.95e-05	0.000325	CcSEcCtD
Ofloxacin—Alopecia—Methotrexate—testicular cancer	6.94e-05	0.000325	CcSEcCtD
Ofloxacin—Bradycardia—Doxorubicin—testicular cancer	6.93e-05	0.000324	CcSEcCtD
Ofloxacin—Mental disorder—Methotrexate—testicular cancer	6.88e-05	0.000322	CcSEcCtD
Ofloxacin—Eye disorder—Epirubicin—testicular cancer	6.87e-05	0.000321	CcSEcCtD
Ofloxacin—Hypersensitivity—Etoposide—testicular cancer	6.87e-05	0.000321	CcSEcCtD
Ofloxacin—Tinnitus—Epirubicin—testicular cancer	6.86e-05	0.00032	CcSEcCtD
Ofloxacin—Erythema—Methotrexate—testicular cancer	6.84e-05	0.00032	CcSEcCtD
Ofloxacin—Malnutrition—Methotrexate—testicular cancer	6.84e-05	0.00032	CcSEcCtD
Ofloxacin—Haemoglobin—Doxorubicin—testicular cancer	6.84e-05	0.00032	CcSEcCtD
Ofloxacin—Cardiac disorder—Epirubicin—testicular cancer	6.82e-05	0.000319	CcSEcCtD
Ofloxacin—Flushing—Epirubicin—testicular cancer	6.82e-05	0.000319	CcSEcCtD
Ofloxacin—Rhinitis—Doxorubicin—testicular cancer	6.82e-05	0.000319	CcSEcCtD
Ofloxacin—Haemorrhage—Doxorubicin—testicular cancer	6.8e-05	0.000318	CcSEcCtD
Ofloxacin—Hepatitis—Doxorubicin—testicular cancer	6.8e-05	0.000318	CcSEcCtD
Ofloxacin—Hypoaesthesia—Doxorubicin—testicular cancer	6.77e-05	0.000316	CcSEcCtD
Ofloxacin—Pharyngitis—Doxorubicin—testicular cancer	6.75e-05	0.000316	CcSEcCtD
Ofloxacin—Urinary tract disorder—Doxorubicin—testicular cancer	6.72e-05	0.000314	CcSEcCtD
Ofloxacin—Oedema peripheral—Doxorubicin—testicular cancer	6.7e-05	0.000313	CcSEcCtD
Ofloxacin—Dysgeusia—Methotrexate—testicular cancer	6.7e-05	0.000313	CcSEcCtD
Ofloxacin—Asthenia—Etoposide—testicular cancer	6.69e-05	0.000313	CcSEcCtD
Ofloxacin—Connective tissue disorder—Doxorubicin—testicular cancer	6.69e-05	0.000313	CcSEcCtD
Ofloxacin—Angiopathy—Epirubicin—testicular cancer	6.67e-05	0.000312	CcSEcCtD
Ofloxacin—Urethral disorder—Doxorubicin—testicular cancer	6.67e-05	0.000312	CcSEcCtD
Ofloxacin—Immune system disorder—Epirubicin—testicular cancer	6.64e-05	0.00031	CcSEcCtD
Ofloxacin—Mediastinal disorder—Epirubicin—testicular cancer	6.63e-05	0.00031	CcSEcCtD
Ofloxacin—Back pain—Methotrexate—testicular cancer	6.62e-05	0.000309	CcSEcCtD
Ofloxacin—Chills—Epirubicin—testicular cancer	6.6e-05	0.000308	CcSEcCtD
Ofloxacin—Pruritus—Etoposide—testicular cancer	6.59e-05	0.000308	CcSEcCtD
Ofloxacin—Arrhythmia—Epirubicin—testicular cancer	6.57e-05	0.000307	CcSEcCtD
Ofloxacin—Visual impairment—Doxorubicin—testicular cancer	6.56e-05	0.000307	CcSEcCtD
Ofloxacin—Alopecia—Epirubicin—testicular cancer	6.5e-05	0.000304	CcSEcCtD
Ofloxacin—Vomiting—Cisplatin—testicular cancer	6.47e-05	0.000302	CcSEcCtD
Ofloxacin—Vision blurred—Methotrexate—testicular cancer	6.45e-05	0.000301	CcSEcCtD
Ofloxacin—Mental disorder—Epirubicin—testicular cancer	6.44e-05	0.000301	CcSEcCtD
Ofloxacin—Erythema multiforme—Doxorubicin—testicular cancer	6.43e-05	0.000301	CcSEcCtD
Ofloxacin—Rash—Cisplatin—testicular cancer	6.41e-05	0.0003	CcSEcCtD
Ofloxacin—Dermatitis—Cisplatin—testicular cancer	6.41e-05	0.0003	CcSEcCtD
Ofloxacin—Erythema—Epirubicin—testicular cancer	6.4e-05	0.000299	CcSEcCtD
Ofloxacin—Malnutrition—Epirubicin—testicular cancer	6.4e-05	0.000299	CcSEcCtD
Ofloxacin—Diarrhoea—Etoposide—testicular cancer	6.38e-05	0.000298	CcSEcCtD
Ofloxacin—Eye disorder—Doxorubicin—testicular cancer	6.36e-05	0.000297	CcSEcCtD
Ofloxacin—Ill-defined disorder—Methotrexate—testicular cancer	6.35e-05	0.000297	CcSEcCtD
Ofloxacin—Tinnitus—Doxorubicin—testicular cancer	6.34e-05	0.000297	CcSEcCtD
Ofloxacin—Anaemia—Methotrexate—testicular cancer	6.32e-05	0.000296	CcSEcCtD
Ofloxacin—Flushing—Doxorubicin—testicular cancer	6.31e-05	0.000295	CcSEcCtD
Ofloxacin—Cardiac disorder—Doxorubicin—testicular cancer	6.31e-05	0.000295	CcSEcCtD
Ofloxacin—Flatulence—Epirubicin—testicular cancer	6.31e-05	0.000295	CcSEcCtD
Ofloxacin—Tension—Epirubicin—testicular cancer	6.28e-05	0.000294	CcSEcCtD
Ofloxacin—Dysgeusia—Epirubicin—testicular cancer	6.27e-05	0.000293	CcSEcCtD
Ofloxacin—Nervousness—Epirubicin—testicular cancer	6.22e-05	0.000291	CcSEcCtD
Ofloxacin—Back pain—Epirubicin—testicular cancer	6.19e-05	0.000289	CcSEcCtD
Ofloxacin—Angiopathy—Doxorubicin—testicular cancer	6.17e-05	0.000289	CcSEcCtD
Ofloxacin—Malaise—Methotrexate—testicular cancer	6.17e-05	0.000288	CcSEcCtD
Ofloxacin—Dizziness—Etoposide—testicular cancer	6.16e-05	0.000288	CcSEcCtD
Ofloxacin—Muscle spasms—Epirubicin—testicular cancer	6.15e-05	0.000288	CcSEcCtD
Ofloxacin—Immune system disorder—Doxorubicin—testicular cancer	6.14e-05	0.000287	CcSEcCtD
Ofloxacin—Vertigo—Methotrexate—testicular cancer	6.14e-05	0.000287	CcSEcCtD
Ofloxacin—Mediastinal disorder—Doxorubicin—testicular cancer	6.13e-05	0.000287	CcSEcCtD
Ofloxacin—Leukopenia—Methotrexate—testicular cancer	6.12e-05	0.000286	CcSEcCtD
Ofloxacin—Chills—Doxorubicin—testicular cancer	6.1e-05	0.000285	CcSEcCtD
Ofloxacin—Arrhythmia—Doxorubicin—testicular cancer	6.08e-05	0.000284	CcSEcCtD
Ofloxacin—Nausea—Cisplatin—testicular cancer	6.04e-05	0.000282	CcSEcCtD
Ofloxacin—Vision blurred—Epirubicin—testicular cancer	6.03e-05	0.000282	CcSEcCtD
Ofloxacin—Alopecia—Doxorubicin—testicular cancer	6.01e-05	0.000281	CcSEcCtD
Ofloxacin—Cough—Methotrexate—testicular cancer	5.97e-05	0.000279	CcSEcCtD
Ofloxacin—Mental disorder—Doxorubicin—testicular cancer	5.96e-05	0.000279	CcSEcCtD
Ofloxacin—Ill-defined disorder—Epirubicin—testicular cancer	5.94e-05	0.000278	CcSEcCtD
Ofloxacin—Vomiting—Etoposide—testicular cancer	5.92e-05	0.000277	CcSEcCtD
Ofloxacin—Erythema—Doxorubicin—testicular cancer	5.92e-05	0.000277	CcSEcCtD
Ofloxacin—Malnutrition—Doxorubicin—testicular cancer	5.92e-05	0.000277	CcSEcCtD
Ofloxacin—Anaemia—Epirubicin—testicular cancer	5.92e-05	0.000277	CcSEcCtD
Ofloxacin—Agitation—Epirubicin—testicular cancer	5.88e-05	0.000275	CcSEcCtD
Ofloxacin—Rash—Etoposide—testicular cancer	5.88e-05	0.000275	CcSEcCtD
Ofloxacin—Dermatitis—Etoposide—testicular cancer	5.87e-05	0.000274	CcSEcCtD
Ofloxacin—Headache—Etoposide—testicular cancer	5.84e-05	0.000273	CcSEcCtD
Ofloxacin—Flatulence—Doxorubicin—testicular cancer	5.84e-05	0.000273	CcSEcCtD
Ofloxacin—Myalgia—Methotrexate—testicular cancer	5.82e-05	0.000272	CcSEcCtD
Ofloxacin—Arthralgia—Methotrexate—testicular cancer	5.82e-05	0.000272	CcSEcCtD
Ofloxacin—Chest pain—Methotrexate—testicular cancer	5.82e-05	0.000272	CcSEcCtD
Ofloxacin—Tension—Doxorubicin—testicular cancer	5.81e-05	0.000272	CcSEcCtD
Ofloxacin—Dysgeusia—Doxorubicin—testicular cancer	5.8e-05	0.000271	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	5.78e-05	0.00027	CcSEcCtD
Ofloxacin—Malaise—Epirubicin—testicular cancer	5.77e-05	0.00027	CcSEcCtD
Ofloxacin—Discomfort—Methotrexate—testicular cancer	5.75e-05	0.000269	CcSEcCtD
Ofloxacin—Nervousness—Doxorubicin—testicular cancer	5.75e-05	0.000269	CcSEcCtD
Ofloxacin—Vertigo—Epirubicin—testicular cancer	5.75e-05	0.000269	CcSEcCtD
Ofloxacin—Syncope—Epirubicin—testicular cancer	5.74e-05	0.000268	CcSEcCtD
Ofloxacin—Leukopenia—Epirubicin—testicular cancer	5.73e-05	0.000268	CcSEcCtD
Ofloxacin—Back pain—Doxorubicin—testicular cancer	5.73e-05	0.000268	CcSEcCtD
Ofloxacin—Muscle spasms—Doxorubicin—testicular cancer	5.69e-05	0.000266	CcSEcCtD
Ofloxacin—Palpitations—Epirubicin—testicular cancer	5.66e-05	0.000264	CcSEcCtD
Ofloxacin—Confusional state—Methotrexate—testicular cancer	5.63e-05	0.000263	CcSEcCtD
Ofloxacin—Loss of consciousness—Epirubicin—testicular cancer	5.63e-05	0.000263	CcSEcCtD
Ofloxacin—Cough—Epirubicin—testicular cancer	5.59e-05	0.000261	CcSEcCtD
Ofloxacin—Anaphylactic shock—Methotrexate—testicular cancer	5.58e-05	0.000261	CcSEcCtD
Ofloxacin—Vision blurred—Doxorubicin—testicular cancer	5.58e-05	0.000261	CcSEcCtD
Ofloxacin—Infection—Methotrexate—testicular cancer	5.55e-05	0.000259	CcSEcCtD
Ofloxacin—Nausea—Etoposide—testicular cancer	5.54e-05	0.000259	CcSEcCtD
Ofloxacin—Hypertension—Epirubicin—testicular cancer	5.53e-05	0.000258	CcSEcCtD
Ofloxacin—Ill-defined disorder—Doxorubicin—testicular cancer	5.49e-05	0.000257	CcSEcCtD
Ofloxacin—Nervous system disorder—Methotrexate—testicular cancer	5.47e-05	0.000256	CcSEcCtD
Ofloxacin—Anaemia—Doxorubicin—testicular cancer	5.47e-05	0.000256	CcSEcCtD
Ofloxacin—Thrombocytopenia—Methotrexate—testicular cancer	5.47e-05	0.000256	CcSEcCtD
Ofloxacin—Chest pain—Epirubicin—testicular cancer	5.45e-05	0.000255	CcSEcCtD
Ofloxacin—Myalgia—Epirubicin—testicular cancer	5.45e-05	0.000255	CcSEcCtD
Ofloxacin—Arthralgia—Epirubicin—testicular cancer	5.45e-05	0.000255	CcSEcCtD
Ofloxacin—Agitation—Doxorubicin—testicular cancer	5.44e-05	0.000254	CcSEcCtD
Ofloxacin—Anxiety—Epirubicin—testicular cancer	5.43e-05	0.000254	CcSEcCtD
Ofloxacin—Skin disorder—Methotrexate—testicular cancer	5.42e-05	0.000253	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	5.41e-05	0.000253	CcSEcCtD
Ofloxacin—Hyperhidrosis—Methotrexate—testicular cancer	5.4e-05	0.000252	CcSEcCtD
Ofloxacin—Discomfort—Epirubicin—testicular cancer	5.38e-05	0.000252	CcSEcCtD
Ofloxacin—Malaise—Doxorubicin—testicular cancer	5.34e-05	0.00025	CcSEcCtD
Ofloxacin—Dry mouth—Epirubicin—testicular cancer	5.33e-05	0.000249	CcSEcCtD
Ofloxacin—Vertigo—Doxorubicin—testicular cancer	5.32e-05	0.000249	CcSEcCtD
Ofloxacin—Anorexia—Methotrexate—testicular cancer	5.32e-05	0.000249	CcSEcCtD
Ofloxacin—Syncope—Doxorubicin—testicular cancer	5.31e-05	0.000248	CcSEcCtD
Ofloxacin—Leukopenia—Doxorubicin—testicular cancer	5.3e-05	0.000248	CcSEcCtD
Ofloxacin—Confusional state—Epirubicin—testicular cancer	5.27e-05	0.000246	CcSEcCtD
Ofloxacin—Palpitations—Doxorubicin—testicular cancer	5.23e-05	0.000245	CcSEcCtD
Ofloxacin—Anaphylactic shock—Epirubicin—testicular cancer	5.22e-05	0.000244	CcSEcCtD
Ofloxacin—Oedema—Epirubicin—testicular cancer	5.22e-05	0.000244	CcSEcCtD
Ofloxacin—Hypotension—Methotrexate—testicular cancer	5.22e-05	0.000244	CcSEcCtD
Ofloxacin—Loss of consciousness—Doxorubicin—testicular cancer	5.21e-05	0.000243	CcSEcCtD
Ofloxacin—Infection—Epirubicin—testicular cancer	5.19e-05	0.000243	CcSEcCtD
Ofloxacin—Cough—Doxorubicin—testicular cancer	5.17e-05	0.000242	CcSEcCtD
Ofloxacin—Shock—Epirubicin—testicular cancer	5.14e-05	0.00024	CcSEcCtD
Ofloxacin—Nervous system disorder—Epirubicin—testicular cancer	5.12e-05	0.000239	CcSEcCtD
Ofloxacin—Thrombocytopenia—Epirubicin—testicular cancer	5.11e-05	0.000239	CcSEcCtD
Ofloxacin—Hypertension—Doxorubicin—testicular cancer	5.11e-05	0.000239	CcSEcCtD
Ofloxacin—Tachycardia—Epirubicin—testicular cancer	5.1e-05	0.000238	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Methotrexate—testicular cancer	5.09e-05	0.000238	CcSEcCtD
Ofloxacin—Skin disorder—Epirubicin—testicular cancer	5.07e-05	0.000237	CcSEcCtD
Ofloxacin—Hyperhidrosis—Epirubicin—testicular cancer	5.05e-05	0.000236	CcSEcCtD
Ofloxacin—Insomnia—Methotrexate—testicular cancer	5.05e-05	0.000236	CcSEcCtD
Ofloxacin—Chest pain—Doxorubicin—testicular cancer	5.04e-05	0.000236	CcSEcCtD
Ofloxacin—Myalgia—Doxorubicin—testicular cancer	5.04e-05	0.000236	CcSEcCtD
Ofloxacin—Arthralgia—Doxorubicin—testicular cancer	5.04e-05	0.000236	CcSEcCtD
Ofloxacin—Anxiety—Doxorubicin—testicular cancer	5.02e-05	0.000235	CcSEcCtD
Ofloxacin—Paraesthesia—Methotrexate—testicular cancer	5.01e-05	0.000234	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	5.01e-05	0.000234	CcSEcCtD
Ofloxacin—Discomfort—Doxorubicin—testicular cancer	4.98e-05	0.000233	CcSEcCtD
Ofloxacin—Anorexia—Epirubicin—testicular cancer	4.98e-05	0.000233	CcSEcCtD
Ofloxacin—Dyspnoea—Methotrexate—testicular cancer	4.98e-05	0.000233	CcSEcCtD
Ofloxacin—Somnolence—Methotrexate—testicular cancer	4.96e-05	0.000232	CcSEcCtD
Ofloxacin—Dry mouth—Doxorubicin—testicular cancer	4.93e-05	0.000231	CcSEcCtD
Ofloxacin—Dyspepsia—Methotrexate—testicular cancer	4.91e-05	0.00023	CcSEcCtD
Ofloxacin—Hypotension—Epirubicin—testicular cancer	4.88e-05	0.000228	CcSEcCtD
Ofloxacin—Confusional state—Doxorubicin—testicular cancer	4.87e-05	0.000228	CcSEcCtD
Ofloxacin—Decreased appetite—Methotrexate—testicular cancer	4.85e-05	0.000227	CcSEcCtD
Ofloxacin—Anaphylactic shock—Doxorubicin—testicular cancer	4.83e-05	0.000226	CcSEcCtD
Ofloxacin—Oedema—Doxorubicin—testicular cancer	4.83e-05	0.000226	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Methotrexate—testicular cancer	4.82e-05	0.000225	CcSEcCtD
Ofloxacin—Fatigue—Methotrexate—testicular cancer	4.81e-05	0.000225	CcSEcCtD
Ofloxacin—Infection—Doxorubicin—testicular cancer	4.8e-05	0.000224	CcSEcCtD
Ofloxacin—Pain—Methotrexate—testicular cancer	4.77e-05	0.000223	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Epirubicin—testicular cancer	4.76e-05	0.000223	CcSEcCtD
Ofloxacin—Shock—Doxorubicin—testicular cancer	4.76e-05	0.000222	CcSEcCtD
Ofloxacin—Nervous system disorder—Doxorubicin—testicular cancer	4.74e-05	0.000222	CcSEcCtD
Ofloxacin—Thrombocytopenia—Doxorubicin—testicular cancer	4.73e-05	0.000221	CcSEcCtD
Ofloxacin—Insomnia—Epirubicin—testicular cancer	4.72e-05	0.000221	CcSEcCtD
Ofloxacin—Tachycardia—Doxorubicin—testicular cancer	4.72e-05	0.000221	CcSEcCtD
Ofloxacin—Skin disorder—Doxorubicin—testicular cancer	4.69e-05	0.000219	CcSEcCtD
Ofloxacin—Paraesthesia—Epirubicin—testicular cancer	4.69e-05	0.000219	CcSEcCtD
Ofloxacin—Hyperhidrosis—Doxorubicin—testicular cancer	4.67e-05	0.000218	CcSEcCtD
Ofloxacin—Dyspnoea—Epirubicin—testicular cancer	4.66e-05	0.000218	CcSEcCtD
Ofloxacin—Somnolence—Epirubicin—testicular cancer	4.64e-05	0.000217	CcSEcCtD
Ofloxacin—Anorexia—Doxorubicin—testicular cancer	4.61e-05	0.000215	CcSEcCtD
Ofloxacin—Feeling abnormal—Methotrexate—testicular cancer	4.6e-05	0.000215	CcSEcCtD
Ofloxacin—Dyspepsia—Epirubicin—testicular cancer	4.6e-05	0.000215	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Methotrexate—testicular cancer	4.56e-05	0.000213	CcSEcCtD
Ofloxacin—Decreased appetite—Epirubicin—testicular cancer	4.54e-05	0.000212	CcSEcCtD
Ofloxacin—Hypotension—Doxorubicin—testicular cancer	4.52e-05	0.000211	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Epirubicin—testicular cancer	4.51e-05	0.000211	CcSEcCtD
Ofloxacin—Fatigue—Epirubicin—testicular cancer	4.5e-05	0.000211	CcSEcCtD
Ofloxacin—Pain—Epirubicin—testicular cancer	4.47e-05	0.000209	CcSEcCtD
Ofloxacin—Constipation—Epirubicin—testicular cancer	4.47e-05	0.000209	CcSEcCtD
Ofloxacin—Urticaria—Methotrexate—testicular cancer	4.43e-05	0.000207	CcSEcCtD
Ofloxacin—Abdominal pain—Methotrexate—testicular cancer	4.41e-05	0.000206	CcSEcCtD
Ofloxacin—Body temperature increased—Methotrexate—testicular cancer	4.41e-05	0.000206	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	4.4e-05	0.000206	CcSEcCtD
Ofloxacin—Insomnia—Doxorubicin—testicular cancer	4.37e-05	0.000204	CcSEcCtD
Ofloxacin—Paraesthesia—Doxorubicin—testicular cancer	4.34e-05	0.000203	CcSEcCtD
Ofloxacin—Dyspnoea—Doxorubicin—testicular cancer	4.31e-05	0.000201	CcSEcCtD
Ofloxacin—Feeling abnormal—Epirubicin—testicular cancer	4.3e-05	0.000201	CcSEcCtD
Ofloxacin—Somnolence—Doxorubicin—testicular cancer	4.3e-05	0.000201	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Epirubicin—testicular cancer	4.27e-05	0.0002	CcSEcCtD
Ofloxacin—Dyspepsia—Doxorubicin—testicular cancer	4.25e-05	0.000199	CcSEcCtD
Ofloxacin—Decreased appetite—Doxorubicin—testicular cancer	4.2e-05	0.000196	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Doxorubicin—testicular cancer	4.17e-05	0.000195	CcSEcCtD
Ofloxacin—Fatigue—Doxorubicin—testicular cancer	4.17e-05	0.000195	CcSEcCtD
Ofloxacin—Urticaria—Epirubicin—testicular cancer	4.15e-05	0.000194	CcSEcCtD
Ofloxacin—Pain—Doxorubicin—testicular cancer	4.13e-05	0.000193	CcSEcCtD
Ofloxacin—Constipation—Doxorubicin—testicular cancer	4.13e-05	0.000193	CcSEcCtD
Ofloxacin—Body temperature increased—Epirubicin—testicular cancer	4.13e-05	0.000193	CcSEcCtD
Ofloxacin—Abdominal pain—Epirubicin—testicular cancer	4.13e-05	0.000193	CcSEcCtD
Ofloxacin—Hypersensitivity—Methotrexate—testicular cancer	4.11e-05	0.000192	CcSEcCtD
Ofloxacin—Asthenia—Methotrexate—testicular cancer	4e-05	0.000187	CcSEcCtD
Ofloxacin—Feeling abnormal—Doxorubicin—testicular cancer	3.98e-05	0.000186	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Doxorubicin—testicular cancer	3.95e-05	0.000185	CcSEcCtD
Ofloxacin—Pruritus—Methotrexate—testicular cancer	3.95e-05	0.000185	CcSEcCtD
Ofloxacin—Hypersensitivity—Epirubicin—testicular cancer	3.85e-05	0.00018	CcSEcCtD
Ofloxacin—Urticaria—Doxorubicin—testicular cancer	3.84e-05	0.00018	CcSEcCtD
Ofloxacin—Abdominal pain—Doxorubicin—testicular cancer	3.82e-05	0.000179	CcSEcCtD
Ofloxacin—Body temperature increased—Doxorubicin—testicular cancer	3.82e-05	0.000179	CcSEcCtD
Ofloxacin—Diarrhoea—Methotrexate—testicular cancer	3.82e-05	0.000179	CcSEcCtD
Ofloxacin—Asthenia—Epirubicin—testicular cancer	3.75e-05	0.000175	CcSEcCtD
Ofloxacin—Pruritus—Epirubicin—testicular cancer	3.7e-05	0.000173	CcSEcCtD
Ofloxacin—Dizziness—Methotrexate—testicular cancer	3.69e-05	0.000173	CcSEcCtD
Ofloxacin—Diarrhoea—Epirubicin—testicular cancer	3.57e-05	0.000167	CcSEcCtD
Ofloxacin—Hypersensitivity—Doxorubicin—testicular cancer	3.56e-05	0.000166	CcSEcCtD
Ofloxacin—Vomiting—Methotrexate—testicular cancer	3.55e-05	0.000166	CcSEcCtD
Ofloxacin—Rash—Methotrexate—testicular cancer	3.52e-05	0.000165	CcSEcCtD
Ofloxacin—Dermatitis—Methotrexate—testicular cancer	3.52e-05	0.000164	CcSEcCtD
Ofloxacin—Headache—Methotrexate—testicular cancer	3.5e-05	0.000163	CcSEcCtD
Ofloxacin—Asthenia—Doxorubicin—testicular cancer	3.47e-05	0.000162	CcSEcCtD
Ofloxacin—Dizziness—Epirubicin—testicular cancer	3.45e-05	0.000161	CcSEcCtD
Ofloxacin—Pruritus—Doxorubicin—testicular cancer	3.42e-05	0.00016	CcSEcCtD
Ofloxacin—Vomiting—Epirubicin—testicular cancer	3.32e-05	0.000155	CcSEcCtD
Ofloxacin—Nausea—Methotrexate—testicular cancer	3.32e-05	0.000155	CcSEcCtD
Ofloxacin—Diarrhoea—Doxorubicin—testicular cancer	3.31e-05	0.000155	CcSEcCtD
Ofloxacin—Rash—Epirubicin—testicular cancer	3.29e-05	0.000154	CcSEcCtD
Ofloxacin—Dermatitis—Epirubicin—testicular cancer	3.29e-05	0.000154	CcSEcCtD
Ofloxacin—Headache—Epirubicin—testicular cancer	3.27e-05	0.000153	CcSEcCtD
Ofloxacin—Dizziness—Doxorubicin—testicular cancer	3.2e-05	0.000149	CcSEcCtD
Ofloxacin—Nausea—Epirubicin—testicular cancer	3.1e-05	0.000145	CcSEcCtD
Ofloxacin—Vomiting—Doxorubicin—testicular cancer	3.07e-05	0.000144	CcSEcCtD
Ofloxacin—Rash—Doxorubicin—testicular cancer	3.05e-05	0.000142	CcSEcCtD
Ofloxacin—Dermatitis—Doxorubicin—testicular cancer	3.04e-05	0.000142	CcSEcCtD
Ofloxacin—Headache—Doxorubicin—testicular cancer	3.03e-05	0.000142	CcSEcCtD
Ofloxacin—Nausea—Doxorubicin—testicular cancer	2.87e-05	0.000134	CcSEcCtD
